Skip to content

Effect of Preoperative Pulmonary Rehabilitation on Short-Term Outcomes in Resectable Stage III Non-Small Cell Lung Cancer After Conversion Therapy: A Prospective Randomized Controlled Trial

Effect of Preoperative Pulmonary Rehabilitation on Short-Term Outcomes in Resectable Stage III Non-Small Cell Lung Cancer After Conversion Therapy: A Prospective Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106368
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung Cancer

Interventions

Intervention group:The intervention group received a two-week preoperative pulmonary rehabilitation program in addition to standard care. Based on individual patient conditions, a home-based exercise
Control group:The control group received standard management, which included routine preoperative assessment, health education, and nutritional support.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Histologically confirmed initially unresectable stage III squamous or non-squamous NSCLC (AJCC 8th edition) before conversion therapy; 2.Completion of >=2–3 cycles of immunotherapy or chemoimmunotherapy for conversion therapy; 3.Multidisciplinary evaluation with imaging (RECIST 1.1) indicating tumor downstaged to resectable status; 4.Age 18–80 years; 5.No contraindications to pulmonary rehabilitation (e.g., myocardial infarction or stroke within 6 months, chronic heart failure, unstable angina, severe arrhythmias, significant left heart dysfunction, acute pulmonary embolism, severe peripheral vascular disease, or limb dysfunction); 6.Voluntary participation with signed informed consent.

Exclusion criteria

Exclusion criteria: 1.Evidence of distant metastasis or concurrent malignancy on imaging; 2.Inability to cooperate (e.g., psychiatric disorder, impaired consciousness, intellectual disability); 3.Intolerance to pulmonary rehabilitation; 4.Presence of contraindications to pulmonary rehabilitation; 5.Other exercise-related contraindications (e.g., active hemoptysis, untreated pneumothorax); 6.Pregnant or lactating participants; 7.Refusal or inability to comply with study procedures.

Design outcomes

Primary

MeasureTime frame
Postoperative pulmonary complications (PPCs);

Secondary

MeasureTime frame
Exercise capacity;Physical activity level;Major symptoms;Quality of life and emotional stress;

Countries

China

Contacts

Public ContactGuowei Che

West China Hospital, Sichuan University

604638284@qq.com+86 189 8060 1890

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026